高级检索
当前位置: 首页 > 详情页

Video-assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non-small cell lung cancer patients

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, China [2]Department of Oncology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China [3]Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China [4]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China [5]Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [6]Department of Thoracic Surgery, Henan Cancer Hospital, Zhengzhou, China [7]Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, Nanjing, China [8]Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China [9]Department of Thoracic Surgery, Chinese People’s Liberation Army General Hospital, Beijing, China [10]Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai, China [11]Department of Thoracic Surgery, First Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, China [12]Department of Thoracic Surgery, China Japan Friendship Hospital, Beijing, China [13]Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, China [14]Medical Affairs, Linkdoc Technology Co, Ltd, Beijing, China
出处:
ISSN:

关键词: Lobectomy overall survival pathological N2 non‐ small cell lung cancer (pN2 NSCLC) perioperative outcomes video‐ assisted thoracic surgery (VATS)

摘要:
Background The majority of previous studies of the clinical outcome of video-assisted thoracoscopic surgery (VATS) versus open lobectomy for pathological N2 non-small cell lung cancer (pN2 NSCLC) have been single-center experiences with small patient numbers. The aim of this study was therefore to investigate these procedures but in a large cohort of Chinese patients with pathological N2 NSCLC in real-world conditions. Methods Patients who underwent lobectomy for pN2 NSCLC by either VATS or thoracotomy were retrospectively reviewed from 10 tertiary hospitals between January 2014 and September 2017. Perioperative outcomes and overall survival of the patients were analyzed. Cox regression analysis was performed to identify potential prognostic factors. Propensity-score analysis was performed to reduce cofounding biases and compare the clinical outcomes between both groups. Results Among 2144 pN2 NSCLC, 1244 patients were managed by VATS and 900 by open procedure. A total of 305 (24.5%) and 344 patients died during VATS and the thoracotomy group during a median follow-up of 16.7 and 15.6 months, respectively. VATS lobectomy patients had better overall survival when compared with those undergoing the open procedure (P < 0.0001). Multivariate COX regression analysis showed VATS lobectomy independently favored overall survival (HR = 0.75, 95% CI: 0.621-0.896, P = 0.0017). Better perioperative outcomes, including less blood loss, shorter drainage time and hospital stay, were also observed in patients undergoing VATS lobectomy (P < 0.05). After propensity-score matching, 169 patients in each group were analyzed, and no survival difference were found between the two groups. Less blood loss was observed in the VATS group, but there was a longer operation time. Conclusions VATS lobectomy might be a feasible alternative to conventional open surgery for resectable pN2 NSCLC. Key points Significant findings of the study: VATS lobectomy has comparative OS in pN2 NSCLC versus open procedure in resectable patients. What this study adds: VATS lobectomy might be feasible for pN2 NSCLC.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学 3 区 呼吸系统
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学 4 区 呼吸系统
JCR分区:
出版当年[2021]版:
Q3 ONCOLOGY Q3 RESPIRATORY SYSTEM
最新[2023]版:
Q2 RESPIRATORY SYSTEM Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, China [*1]Department of Thoracic Surgery,Tangdu Hospital, Fourth Military MedicalUniversity, No.569 Xinsi Road, Baqiao District,Xi’an 710038, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号